No Detail Found!

Surgical Outcome of Upper Gastrointestinal Malignancies.

Author(s)
Adnan Yousaf Department of General Surgery, Khyber Teaching Hospital, Peshawar, Pakistan
Mushtaq Ahmad Department of General Surgery, Khyber Teaching Hospital, Peshawar, Pakistan
Rashid Waheed Department of General Surgery, Khyber Teaching Hospital, Peshawar, Pakistan
Muhammad Muslim Department of General Surgery, Khyber Teaching Hospital, Peshawar, Pakistan
Mahmud Aurangzeb Department of General Surgery, Khyber Teaching Hospital, Peshawar, Pakistan
Nisar Ahmed Department of General Surgery, Khyber Teaching Hospital, Peshawar, Pakistan
Asad Maroof Department of General Surgery, Khyber Teaching Hospital, Peshawar, Pakistan
Abstract
Objective: To evaluate the surgical outcome of upper Gastrointestinal (GI) malignancies. Material and Methods: This cross-sectional study was conducted at Department of Surgery, Khyber Teaching Hospital, Peshawar from January 2012 to December 2014. One hundred and ninty patients of either gender, diagnosed as having upper GI malignancy (esophageal, gastric, pancreatic, gall bladder) on the basis of histopathology were included in the study. Detailed information was recorded about the age and gender distribution, staging of respective cancer, surgical management, and post-operative morbidity and mortality. Results: Of the 190 patients with upper GI malignancies, 88 (46%) had esophageal carcinoma; 47 (25%) had gastric carcinoma, 27 (14%) had pancreatic carcinoma and 28 (15%) had gall bladder cancer. 80.68% of the esophageal cancers were adenocarcinomas and 19.31% were squamous cell carcinomas based on histopathology reports. Males were predominantly affected (69.31%). Majority (73.86%) patients were diagnosed in stage III esophageal cancer. Transhiatal esophagectomy was the surgery of choice in 78.40% of the patients with esophageal cancer. Post-operatively, 30 day mortality was 11%. Among the gastric cancer patients, 65% had adenocarcinoma; 20% had squamous cell carcinoma; 10% had Gastrointestinal Stromal Tumor (GIST); and 5% had gastric lymphoma. Again, males were predominantly involved (55%). Majority (56.52%) of the patients were diagnosed in stage IV of gastric carcinoma. Only 10 patients underwent surgery, while the remaining 13 received palliative therapy. 30-day post-operative mortality was 20%. Three of the 27 pancreatic cancers were adenocarcinomas. Males were predominantly affected (66.66%). Five patients underwent Whipple's Procedure, of whom 2 expired. Female to male ratio in gall bladder cancer was 3:1 (75%: 25%). Ninty percent of the patients presented with advanced disease. Six month survival rate was <2%. Conclusion: Esophageal and gastric carcinomas are the most frequently encountered upper GI malignancies. If diagnosed at an early stage, all malignancies carry a better prognosis with appropriate surgical intervention. Late presentation carries a poor prognosis.
Publication Details
Page(s) 32-35
DOI DOI not available
Published Journal: Journal of Medical Science, Volume: 24, Issue: 1, Year: 2016

Request the full text from PASTIC

References
2002., 359 -90
GoreRM,MillerFH,BraggDG,RubinP,HricakH, 2002.Stomach cancer,Oncologic Imaging 391 -418
NationalCancer Guidance Steering Group, 2000.,Improving Outcomes in Upper Gastro-intestinal Cancers: The Research Evidence London: NHS Executive -
NationalCancer Guidance Steering Group, 2000.,Improving Outcomes in Upper Gastro-intestinal Cancers: The Manual London: NHS Executive -
2009.Pattern of upper Gastaro Intestinal malignancies in Northern Punjab,Pak J Med Sci 25 302 -7
KhanSM,GillaniJ,NasreenS,ZaiS., 1997.Cancer in North West Pakistan and Afghan Refugees,JPMA 47 122 -24
NI Cancer Registry, 2005.Monitoring of Care of Patients with Upper GI Cancers in Northern Ireland in, -
LeeSS,HaHK,ShinYM, 2005.Superficial esophageal cancer: esophagogastric findings correlated with histopathologic findings,Radiology 236 535 -44
LagardeSM,Ten KateFJ,ReitsmaJB,BuschOR,Van LanschotJJ, 2006.Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction,J Clin Oncol 24 4347 -55
1999.Office for National Statistics, -
DalyJM,FryWA,LittleAG,WinchesterDP,McKeeRF,StewartAK, 2000.Esophageal cancer: results of an American College of Surgeons patient care evaluation study,JACS 190 562 -72
CrewKD,NeugutAI, 2006.Epidemiology of gastric cancer,World J Gastroenterol 12 354 -62
AllumWH,PowellDJ,McConkeyCC,FieldingJWL, 1989.Gastric cancer: A 25-year review,Br J Surg 76 535 -40
BachmannM,AldersonD,PetersT, 1999.Survival, clinical practice and costs in patients with pancreatic, oesophageal and gastric cancers: influences of doctor and hospital volumes,Bristol: Departments of Social Medicine and Surgery -
InformationService, 1999.Northern and Yorkshire Cancer Registry,Quick data -
InformationService, 1999.Cancer treatment policies and their effects on survival: Pancreas, -
CristDW,SitzmanJV,CameronJL, 1987.Improved hospital morbidity, mortality and survival after the Whipple procedure,Ann Surg 206 358 -65
BraaschJW,DezielDJ,RossiRL, 1986.Pyloric and gastric preserving pancreatic resection,Experience with 87 patients. Ann Surg 204 411 -18
TredeM,SchwallG,SaegerH, 1990.Survival after pancreaticoduonectomy: 118 consecutive resections without an operative mortality,Ann Surg 211 447 -58
YeoCJ,CameronJL,LillemoeKD, 1995.Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients,Ann Surg 221 721 -33
HeXD,LiJJ,LiuW,QuQ,HongT,XuXQ, .Surgical procedure determination based on tumor-node-metastasis staging of gallbladder cancer,World J Gastroenterol. 2015 Apr 21 4620 -26
0

Citations

0

Downloads

43

Views